Logo
Logo

Do you have a project in your
mind? Keep connect us.

Contact Us

  • +44 454 7800 112
  • infotech@arino.com
  • 50 Wall Street Suite, 44150 Ohio, United States

Subscribe

At vero eos et accusamus et iusto odio as part dignissimos ducimus qui blandit.

VoT 2024

About

The VoT – Voices of Tomorrow 2024 is an online global bio-innovation competition that aims to inspire, empower and develop the next generation of bioentrepreneurs and business decision-makers. The ONLINE initiative is designed to offer practical experience and hands-on training at the intersection of science and business, allowing participants to emerge with the entrepreneurial and problem-solving skills to make a real-world impact in the biotech industry.

Applications for this year is launching soon - Stay tuned with our social media!

Facebook Twitter Instagram Youtube

Format

The competition attracts 150 participants worldwide and is organized across three learning tracks: Innovation and Entrepreneurship, Consulting and Venture
Capital.

EVERY PARTICIPANT WILL BE ASSIGNED TO ONE LEARNING TRACK, AND over a 3-month period from September to November 2024,
participants will have the opportunity to experience real-world working scenarios in each learning track through masterclasses, mentorship sessions, and case
studies.

The VoT competition will conclude with a pitch competition, where each team will have the opportunity to present the outcomes of their assigned tasks,
and prizes will be awarded to the winning teams. In more details:

Mentorship Sessions

Each team will engage with a mentor weekly, receiving valuable insights and guidance for executing the deliverables.

Masterclasses

Each learning track will feature a weekly workshop delivered by a seasoned professional, who will share information, insights and expertise on a specific topic.

Panel Discussions

During the opening and final days of the competition, participants will learn from experts who will discuss recent trends, challenges, and opportunities within the biotech industry.

Confirmed speakers

Prof. Maria Leptin

President, European Research Council

Prof. Marcus Schindler

Executive VP & Chief Scientific Officer, Novo Nordisk A/S

Dr. Matthias Evers

Chief Business Officer, Evotec

Dr. Melanie Lee

Chief Executive Officer, LifeArc

Sir Gregory Winter

Nobel Laureate, Trinity College Cambridge

Alexander Hardy

Chief Executive Officer, Genentech

Ms. Julie Kim

President U.S. Business Unit and U.S. Country Head, Takeda

Mr. Hans Bishop

President, Altos Labs

Dr. Jonathon Sedgwick

Vice President and Global Head, Discovery Research, AbbVie

Ms. Cristina Duran

Chief Digital Health Officer R&D, AstraZeneca

Mr. Thierry Bernard

Chief Executive Officer, QIAGEN

Ms Hannah Kuchler

Global pharmaceuticals correspondent, Financial Times
Our reputed world wide partners
Our reputed world wide partners